These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 10575045)

  • 1. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.
    Benmansour S; Cecchi M; Morilak DA; Gerhardt GA; Javors MA; Gould GG; Frazer A
    J Neurosci; 1999 Dec; 19(23):10494-501. PubMed ID: 10575045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter.
    Benmansour S; Owens WA; Cecchi M; Morilak DA; Frazer A
    J Neurosci; 2002 Aug; 22(15):6766-72. PubMed ID: 12151556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
    Zhao Z; Zhang HT; Bootzin E; Millan MJ; O'Donnell JM
    Neuropsychopharmacology; 2009 May; 34(6):1467-81. PubMed ID: 18923402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice.
    Montañez S; Owens WA; Gould GG; Murphy DL; Daws LC
    J Neurochem; 2003 Jul; 86(1):210-9. PubMed ID: 12807440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
    Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain.
    Gould GG; Javors MA; Frazer A
    Biol Psychiatry; 2007 Jan; 61(2):210-5. PubMed ID: 16650830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons.
    Montañez S; Daws LC; Gould GG; Frazer A
    J Neurochem; 2003 Nov; 87(4):861-7. PubMed ID: 14622117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of antidepressant treatment on serotonergic and dopaminergic systems in Fawn-Hooded rats: a quantitative autoradiography study.
    Chen F; Lawrence AJ
    Brain Res; 2003 Jun; 976(1):22-9. PubMed ID: 12763618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the norepinephrine transporter by chronic administration of antidepressants.
    Benmansour S; Altamirano AV; Jones DJ; Sanchez TA; Gould GG; Pardon MC; Morilak DA; Frazer A
    Biol Psychiatry; 2004 Feb; 55(3):313-6. PubMed ID: 14744474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry.
    Daws LC; Montañez S; Owens WA; Gould GG; Frazer A; Toney GM; Gerhardt GA
    J Neurosci Methods; 2005 Apr; 143(1):49-62. PubMed ID: 15763136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization and visualization of the glial serotonin transporter.
    Inazu M; Takeda H; Ikoshi H; Sugisawa M; Uchida Y; Matsumiya T
    Neurochem Int; 2001 Jul; 39(1):39-49. PubMed ID: 11311448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters.
    Daws LC; Toney GM; Gerhardt GA; Frazer A
    J Pharmacol Exp Ther; 1998 Aug; 286(2):967-76. PubMed ID: 9694957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems.
    Gould GG; Pardon MC; Morilak DA; Frazer A
    Neuropsychopharmacology; 2003 Sep; 28(9):1633-41. PubMed ID: 12825093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants.
    Mortensen OV; Kristensen AS; Wiborg O
    J Neurochem; 2001 Oct; 79(2):237-47. PubMed ID: 11677251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.
    Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
    Synapse; 2003 Feb; 47(2):123-33. PubMed ID: 12454950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine.
    Benmansour S; Piotrowski JP; Altamirano AV; Frazer A
    Neuropsychopharmacology; 2009 Feb; 34(3):555-64. PubMed ID: 18322468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bi-phasic change in BDNF gene expression following antidepressant drug treatment.
    Coppell AL; Pei Q; Zetterström TS
    Neuropharmacology; 2003 Jun; 44(7):903-10. PubMed ID: 12726822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat.
    Paczkowski NJ; Vuocolo HE; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):423-30. PubMed ID: 8935709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of serotonin transporter mRNA in rat brain: presence in neuronal and non-neuronal cells and effect of paroxetine.
    Swan MC; Najlerahim AR; Bennett JP
    J Chem Neuroanat; 1997 Jul; 13(2):71-6. PubMed ID: 9285352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.